Dr Gold is a consultant and performs clinical research for Stratpharma. He is also performing clinical research for Biofrontera and is a consultant to Sensus Healthcare. He has been a consultant to Dusa Pharmaceuticals and performed clinical research for them in the past.

Latest Contribution


What’s new on the horizon for toxins coming to the market?

With the ever increasing demand for injectable treatments, it is important to keep abreast of new developments in the field. International expert Michael Gold reviews the new toxins due to be hitting the market in the next year. We are...


What’s new in treating hypertrophic scars and keloids?

World renowned dermatologist, Michael H Gold, explains new treatments available in the challenging field of hypertrophic scar and keloid management. The treatment of hypertrophic scars and keloids remains one of the most challenging conditions that dermatologists face on a regular...